CEPI, the Coalition for Epidemic Preparedness Innovations, yesterday announced a $43.5 million deal with pharmaceutical giant AstraZeneca to advance the development of a novel antibody that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback